Zymar

DRUG2 trials

Sponsors

Stanford University, Laboratorios Sophia S.A de C.V.

Conditions

Conjunctivitis, BacterialOphthalmic Surgery

Phase 3

Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.

TerminatedNCT03696342

Laboratorios Sophia S.A de C.V.Conjunctivitis, Bacterial

Start: 2018-10-01End: 2020-03-24Updated: 2021-08-24

Phase 4

One Hour Preoperative Gatifloxacin

CompletedNCT00350363

Stanford UniversityOphthalmic Surgery

Start: 2007-01-31End: 2010-12-31Updated: 2015-01-29